Neobe Therapeutics
Engineers live bacterial therapeutics to help immunotherapies reach solid tumours in patients with immune-excluded cancers
Highlights
- New on EvolcAdded 2026-11-07
Recent signals
What changed at Neobe Therapeutics in the last 6 months, newest first. Each line links to its public source.
- 10 Nov 2026 In the news · London-based Neobe raises €6.1 million to engineer bacteria that break down barriers protecting cancer tumours eu-startups.com
About Neobe Therapeutics
Neobe Therapeutics is building a synthetic biology platform that engineers live bacterial therapeutics to colonise solid tumours and remodel their microenvironment, enabling immune cells to reach tumours and supporting immunotherapy.
Its programmes target colorectal, pancreatic and breast cancers. The company is based in Cambridge and has a laboratory at Stevenage Bioscience Catalyst in Hertfordshire; its programmes include preclinical and IND-enabling work.
Product: A synthetic biology platform and engineered live biotherapeutic programmes designed to remodel solid tumour microenvironments.
Jobs at Neobe Therapeutics
Leadership
- Annelise Soulier · Co-founder and CSOSource: company website
- Pedro Correa de Sampaio · Co-founder and CEOSource: company website
- Joe Turner · Fractional CFOSource: company website
More biotech & pharma companies
Neoceuticals
Paediatric and specialist oral medicines and nutritional products for healthcare markets in the UK and overseasNew on EvolcNeon Healthcare
Supplies prescription medicines to hospitals, pharmacies and other healthcare providersNew on EvolcNeovac
Develops lipid platforms and formulation kits for researchers advancing RNA therapeuticsNew on EvolcNeurolieve Biosciences
Developing a non-opioid biologic for patients with neuropathic pain, designed to relieve pain and support nerve regenerationYoung companyNew on EvolcNexus Bioquest
Immunology CRO running custom assays and pre-clinical drug discovery studies for pharma and biotech teamsYoung companyNew on EvolcNiche Generics
Generic oral medicines supplied to UK wholesalers and distribution partners in Europe and other territoriesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SanityMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Frontend frameworks
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Next.js
Hosting
- NetlifyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-nf-request-id
- Response headerx-nf-request-id
- Response headerx-nf-request-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.